European Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bnEuropean Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bnEuropean Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 23 · Tue 17 Nov 

Companies

atai Therapeutics

atai Therapeutics, Inc.

HQ
United States
Status
active
Listing
Private
Current stage
subsidiary within AtaiBeckley group

clinicaltrials.govregistryverified 2026-11-02

Notes on the record

Current sponsor of record for VLS-01 (NCT06524830), ibogaine (NCT05029401) and EMP-01 (NCT06693609). This is the sponsor-name variant to sweep on ClinicalTrials.gov; older variants return zero. RE-VERIFIED 2026-11-02, no field changed: ClinicalTrials.gov v2 API gives atai Therapeutics, Inc. as lead sponsor of NCT06524830 (now COMPLETED), NCT05029401 and NCT06693609 (both COMPLETED). Supersedes the row verified 2026-08-24 (kept), per DATA LAYER rule 4.

Assets

  • VLS-01

    Phase 2b complete: NCT06524830 (ELUMINA) COMPLETED on ClinicalTrials.gov, primary completion 2026-07-30 ACTUAL, study completion 2026-10-16 ACTUAL, enrollment 142 ACTUAL, record last updated 2026-10-30, no results posted as of 2026-11-02; last patient dosed 2026-07-06; Phase 3 in MDD planned · treatment-resistant depression; planned MDD

    clinicaltrials.govregistryverified 2026-11-02

Registered trials

  • NCT06524830ClinicalTrials.gov

    PHASE2 · Treatment Resistant Depression · COMPLETED · Australia, Canada, United Kingdom, United States

    clinicaltrials.govctgov registryverified 2026-11-02

Deals

This company is not a party to any row in data/deals.csv.

In the briefing

1 issue tagged ATAI-THERAPEUTICS.

Record history